Sign up for our complimentary
weekly e-journal

 
Bookmark and Share | Print | Category | Home Previous | All Articles This Week | Next
This article originally posted 19 November, 2009 and appeared in  Issue 496

Fasting Not Required for Cholesterol Test

Patients do not need to fast before having their cholesterol tested, a major study has found. 

Advertisement

Cholesterol tests are used as a key part of assessing a patient's risk of cardiovascular problems. Fasting has been recommended as it had been thought the body needed enough time to digest food in the system and to clear any fatty particles from the blood. This was in order to produce an accurate reading of so-called "bad" cholesterol -- or low-density lipoprotein (LDL).

However, Naveed Sattar, Professor of Metabolic Medicine and Chris Packard, an Honorary Professor in Developmental Medicine, both of the University of Glasgow, together with researchers from the University of Cambridge, found that test results were just as accurate without fasting.

"After analysing data from 300,000 patients, the results were just as accurate if the patient had eaten before the test," said Professor Sattar.

Lead researcher John Danesh, Professor of Epidemiology and Medicine at the University of Cambridge, continued, "For decades, people have been asked to fast overnight before their cholesterol tests. Our findings indicate that cholesterol measurements are at least as good -- and probably somewhat better -- when made without fasting."

The study also adds to the ongoing controversy over whether testing for blood proteins called apolipoproteins is a more reliable way of predicting heart risk than cholesterol testing.

"The studies showed that analyzing "good" cholesterol -- or high-density lipoprotein (HDL) in conjunction with LDL was just as informative as testing for apolipoproteins AI and B. Furthermore our paper shows that once "bad" cholesterol and "good" HDL-cholesterol are known, using the levels of triglycerides or fat in the blood, as a means to predict the risk of heart disease, is unhelpful," said Professor Sattar.

Professor Peter Weissberg, Medical Director of the British Heart Foundation, which funded the study, said, "Given the pressure the NHS is under, it is good news that doctors don't need to spend money on setting up more sophisticated tests based on apolipoproteins. But the study underlines the importance of all GP's being able to measure HDL cholesterol as well as total cholesterol in order to make the best predictions about heart disease risk."

The Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009; 302: 1993-2000

 

 

Bookmark and Share | Print | Category | Home

This article originally posted 19 November, 2009 and appeared in  Issue 496

Past five issues: Issue 537 | Issue 536 | Issue 535 | Issue 534 | Issue 533 |

Recent Most Read Articles:

Obesity Reduces Survival By 2 Years
Posted March 31, 2009
Not Enough Sleep Causes More Eating and Diabetes Risk
Posted May 01, 2009
Test Your Knowledge Issue 469
Posted May 19, 2009
Generex Biotechnology Announces Successful Phase III Study Data for Generex Oral-lyn(tm)
Posted March 17, 2009
Test Your Knowledge Issue 457
Posted February 24, 2009
Discovery of a New Receptor Antagonist Predicts Diabetes 2 Onset
Posted April 18, 2009
A Spoonful of Vinegar Helps the Sugar Go Down
Posted February 08, 2005
Letter From The Editor. June 29, 2009 Issue #475
Posted June 29, 2009
Artificial Sweeteners Linked to Two-Fold Increase in Diabetes
Posted June 23, 2009
Lantus Insulin: A Possible Link with Cancer - Requires Further Investigation
Posted June 29, 2009

See more most read...


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Marilyn Porter, RD, CDE | Melissa Diane Smith | Paul Chous, M.A., OD | Philip A. Wood PhD | Sheri R. Colberg PhD | Sherri Shafer | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |
Diabetes In Control Advertisers
Cast Your Vote
What percent of your Type 2 patients are on oral triple therapy and have an A1c below 6.4%?
Featured Jobs
CME/CE of the Week
Category: Nutrition
CE Credits: .75
 

Free Weekly Newsletter
Sign up here.

Free CE Available
CE Programs on diabetes

Sponsored Link


Advertisement


Advertisement




Search Articles On Diabetes In Control